Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXCP.L Regulatory News (MXCP)

  • There is currently no data for MXCP

Placing and Acquisition

17 Jul 2014 07:00

RNS Number : 5522M
Broca plc
17 July 2014
 

Broca plc

("Broca"or the "Company")

Conditional Placing, Proposed Acquisition, Reverse Takeover and Temporary Suspension of Shares

 

The board of directors of Broca (the "Board") announces the following:

- A conditional placing of new ordinary shares to raise £8.5 million (the 'Placing')

- The proposed acquisition of MXC Capital Advisory LLP (the 'Acquisition'), constituting a Reverse Takeover under the AIM Rules

- The temporary suspension of trading in the Company's ordinary shares

Should the Placing and Acquisition be approved by shareholders the Company will become an Investment and Advisory business seeking to generate shareholder returns by making significant minority investments in growth technology businesses while supporting them with advisory services. The key attributes of the Company will be:

 

· a merchant banking ethos of shared risk and reward with investee companies

· a focus on the technology, media and telecommunications ("TMT") sector

· a corporate finance advisory practice that will augment the investment strategy by providing specialist corporate finance advice to Broca investee companies

· MXC Capital will act as consultant to the Company, with the specific remit of introducing suitable investment opportunities

 

The founders of MXC Capital have more than 50 years' collective experience in TMT sector, having concluded more than £400m of transactions in the last ten years. Recent examples of MXC Capital's investment and advisory activity include Redstone Plc, Redcentric plc and Accumuli plc

 

Conditional Placing

On 16 April 2014, Broca announced that it had disposed of its operating business and was now an Investing Company under Rule 15 of the AIM Rules for Companies (the "AIM Rules"), focused on making acquisitions and/or investments within the TMT sector.

Consistent with this policy, the Board has identified a strong pipeline of potential TMT investments and believes that (taking advantage of the access to further capital that having a listing on AIM affords the Company) undertaking a placing of new ordinary shares, together with the cash the Company already has at its disposal, will leave it well positioned to take advantage of the opportunities currently under evaluation.

The Company has therefore conditionally raised £8.5 million before expenses (the "Placing") through the placing of 850,000,000 ordinary shares (the "Placing Shares") at a price of 1p per share (the "Placing Price").

The Placing Price represents a discount of approximately 32.20 per cent. to the closing mid-market price of 1.475p on 16 July 2014, being the last practicable dealing day prior to the publication of this announcement and is equal to the price at which ordinary shares were last placed by the Company in July 2013. The Placing Shares will represent approximately 68.16 per cent. of the Company's share capital, as enlarged by the Placing Shares.

The Placing Shares, which will rank pari passu in all respects with the Company's outstanding ordinary shares, have been conditionally allotted subject to, among other things, the approval of shareholders at a General Meeting of the Company (the "EGM") and admission of the Placing Shares to trading on AIM.

Ian Smith, Chairman of the Company, is subscribing for 13,000,000 new ordinary shares in the Placing. Following his subscription, Ian Smith's beneficial holding in the Company will be 13,000,000 ordinary shares representing 1.04% of the enlarged issued share capital of the Company following completion of the Placing.

Simon Duckworth, Non-Executive Director of the Company, and Caroline Duckworth, his wife, are subscribing for a total of 5,000,000 new ordinary shares in the Placing. Following their subscription, Simon and Caroline Duckworth's beneficial holding in the Company will be 5,000,000 ordinary shares representing 0.40% of the enlarged issued share capital of the Company following completion of the Placing.

Related Party Transactions

MXC Capital's participation in the Placing

MXC Capital Limited ("MXC Capital") is proposing to subscribe for 300,000,000 Placing Shares in the Placing. MXC Capital's participation in the Placing is classified as a related party transaction for the purposes of Rule 13 of the AIM Rules as MXC Capital is a Substantial Shareholder in Broca (as defined in the AIM Rules) and because Ian Smith is a director of both Broca and MXC Capital.

Jill Collighan, who is not involved in the transaction and is therefore independent, considers, having consulted with the Company's nominated adviser, Zeus Capital, that the terms of MXC Capital's participation in the Placing are fair and reasonable insofar as the Company's shareholders are concerned.

Ian Smith's participation in the Placing

Ian Smith is proposing to subscribe for 13,000,000 Placing Shares in the Placing. Ian Smith's participation in the Placing is classified as a related party transaction for the purposes of Rule 13 of the AIM Rules. This is due to the fact that Ian Smith is a director of Broca.

Jill Collighan, who is not involved in the transaction and is therefore independent, considers, having consulted with the Company's nominated adviser, Zeus Capital, that the terms of Ian Smith's participation in the Placing are fair and reasonable insofar as the Company's shareholders are concerned.

Simon Duckworth's participation in the Placing

Simon Duckworth and Caroline Duckworth are proposing to subscribe for 5,000,000 Placing Shares between them in the Placing. Simon Duckworth and Caroline Duckworth's participation in the Placing is classified as a related party transaction for the purposes of Rule 13 of the AIM Rules. This is due to the fact that Simon Duckworth is a Non-Executive Director of the Company.

Jill Collighan, who is not involved in the transaction and is therefore independent, considers, having consulted with the Company's nominated adviser, Zeus Capital, that the terms of Simon Duckworth's participation in the Placing are fair and reasonable insofar as the Company's shareholders are concerned.

Helium Special Situations Fund's participation in the Placing

Helium Special Situations Fund is proposing to subscribe for 20,000,000 Placing Shares in the Placing. Helium Special Situations Fund's participation in the Placing is classified as a related party transaction for the purposes of Rule 13 of the AIM Rules. This is due to the fact that Helium Special Situations Fund is a Substantial Shareholder in Broca for the purposes of the AIM Rules.

Jill Collighan, who is not involved in the transaction and is therefore independent, considers, having consulted with the Company's nominated adviser, Zeus Capital, that the terms of Helium Special Situations Fund's participation in the Placing are fair and reasonable insofar as the Company's shareholders are concerned.

Nigel Wray's participation in the Placing

Nigel Wray is proposing to subscribe for 300,000,000 Placing Shares in the Placing. Nigel Wray's participation in the Placing is classified as a related party transaction for the purposes of Rule 13 of the AIM Rules. This is because Nigel Wray is a Substantial Shareholder in Broca for the purposes of the AIM Rules.

Jill Collighan, who is not involved in the transaction and is therefore independent, considers, having consulted with the Company's nominated adviser, Zeus Capital, that the terms of Nigel Wray's participation in the Placing are fair and reasonable insofar as the Company's shareholders are concerned.

Proposed Acquisition of MXC Capital Advisory LLP

The Company is in advanced discussions relating to the purchase of MXC Capital Advisory LLP (the "Acquisition"), a specialist TMT corporate finance advisory business which is authorised and regulated by the Financial Conduct Authority and currently owned by MXC Capital.

Consistent with the Company's stated Investing Policy, the commercial rationale behind the acquisition is to bring sufficient expertise in-house to allow the Company to take full advantage of a strengthened balance sheet and allow the Board to properly consider the numerous opportunities currently being evaluated as well as enabling the Company to execute potential transactions.

This Acquisition will constitute a reverse takeover under the AIM Rules for Companies and will therefore be subject to, among other things, the approval of shareholders at the EGM. It is anticipated that following the acquisition of MXC Capital Advisory LLP the Company will no longer be classified as an Investing Company pursuant to Rule 15 of the AIM Rules.

Further details of the Acquisition, including the key commercial terms, will be released to the market in due course.

Temporary Suspension of Trading in the Company's Shares

As the Acquisition will be deemed a reverse take-over under the AIM Rules, the Company has requested that trading in its ordinary shares be suspended with effect from 7.30 a.m. on 17 July 2014 pending the publication of the Admission Document.

Further details regarding the proposed Acquisition and Placing will be set out in the Admission Document. However, the proposed Acquisition remains under negotiation and is subject to certain conditions; there is therefore no certainty that it will be completed on the terms currently proposed or at all.

Further announcements will be made in due course, as required.

 

Broca plc

Jill Collighan, Finance Director

Simon Duckworth, Non-Executive Director

+44 (0) 20 7965 8149

Zeus Capital Limited (Nominated adviser and broker)

Tim Metcalfe/John Depasquale/John Treacy

+44 (0)20 7533 7727

MXC Capital Advisory LLP

Marc Young

+44(0)20 7965 8149

Newgate Threadneedle

Josh Royston

+44 (0)20 7653 9850

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQKADKKBKBNOD
Date   Source Headline
5th Mar 200711:34 amRNSResult of EGM
2nd Mar 20073:07 pmRNSDirector/PDMR Shareholding
26th Feb 20074:22 pmRNSIssue of Equity
22nd Feb 20073:53 pmRNSHolding(s) in Company
16th Feb 20077:01 amRNSProposed Demerger
8th Feb 200712:48 pmRNSHolding(s) in Company
6th Feb 20072:47 pmRNSHolding(s) in Company
5th Feb 200710:47 amRNSHolding(s) in Company
29th Jan 20073:28 pmRNSAGM Statement
29th Jan 20077:01 amRNSTrading Statement
4th Jan 20075:56 pmRNSIssue of Options
3rd Jan 20074:33 pmRNSNotice of AGM
21st Dec 20063:35 pmRNSDirector/PDMR Shareholding
15th Dec 20069:00 amRNSTotal Voting Rights
27th Nov 20063:55 pmRNSTransaction in Own Shares
22nd Nov 20067:00 amRNSFinal Results
9th Nov 20064:34 pmRNSNotice of Results
16th Oct 20067:00 amRNSTrading Statement
21st Sep 20067:03 amRNSAgreement with Multimap
11th Sep 20067:03 amRNSAcquisition of Proteus Inc
30th Aug 20063:55 pmRNSTransaction in Own Shares
21st Aug 20067:00 amRNSAdditional Listing
19th Jul 200610:46 amRNSMobile Payment Scheme
19th Jul 20067:01 amRNSMobile Payment Scheme
17th Jul 20067:00 amRNSAcquisition
7th Jul 20061:50 pmRNSTreasury Shares
15th May 20064:10 pmRNSHolding(s) in Company
11th May 20068:49 amRNSTreasury Shares
8th May 20067:00 amRNSInterim Results
26th Apr 20064:06 pmRNSNotice of Results
27th Mar 20063:26 pmRNSEGM Statement
23rd Mar 20062:40 pmRNSNotification of Shareholding
1st Mar 20067:01 amRNSNotice of EGM
28th Feb 20067:01 amRNSUS Distribution Deal
6th Feb 20064:36 pmRNSDirector/PDMR Shareholding
3rd Feb 20067:00 amRNSGrant of Share Options
30th Jan 200612:01 pmRNSAGM Statement
30th Jan 20067:00 amRNSTrading Statement
29th Dec 200510:18 amRNSDirectorate Change
28th Dec 200512:31 pmRNSShare Buy Back
1st Dec 200512:26 pmRNSHolding(s) in Company
28th Nov 20057:00 amRNSPlacing
21st Nov 20057:00 amRNSFinal Results
16th Nov 20059:00 amRNSNotice of Results
24th Oct 20057:00 amRNSJoint Venture
14th Oct 20057:00 amRNSUS SMS Alert Service
15th Sep 20057:04 amRNSAhead of Market Forecasts
14th Sep 20057:01 amRNSSecurity Patent Acquired
5th Sep 200511:05 amRNSHolding(s) in Company
8th Aug 20057:00 amRNSLaunch of Business Initiative

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.